Beneficial effect of beraprost sodium plus telmisartan in the prevention of arterial stiffness development in elderly patients with hypertension and cerebral infarction

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 6, 2007, Pages 309-314

  Nakayama, Tomohiro ^a   Masubuchi, Yuichi ^a   Kawauchi, Kazunori ^a   Masaki, Riko ^a   Hironaga, Takashi ^b   Ishima, Hatsue ^b   Torigoe, Mami ^b   Shimabukuro, Hiroaki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kimura Makizumi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; TELMISARTAN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY COMPLIANCE; ARTICLE; BRAIN INFARCTION; BRAIN PROTECTION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENCY; FEMALE; FOLLOW UP; HEART PROTECTION; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT MONITORING; PRIORITY JOURNAL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ARTERIOSCLEROSIS; BENZIMIDAZOLES; BENZOATES; BLOOD FLOW VELOCITY; CEREBRAL INFARCTION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION; MALE; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME;

EID: 34447623363     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.05.004     Document Type: Article

References (25)

1. Lehmann E.D., Riley W.A., Clarkson P., and Gosling R.G. Noninvasive assessment of cardiovascular disease in diabetes mellitus. Lancet 350 Suppl. l (1997) 14-19
2. Amar J., Ruidavets J.B., Chamontin B., Drouet L., and Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. J. Hypertens. 19 (2001) 381-387
3. Safar M.E., Tual J.L., Safavian A., and London G.M. Antihypertensive therapy and wave reflections. Prostaglandins Leukot. Essent. Fatty Acids 54 (1996) 71-76
4. Murata T., Murai T., Kanai T., et al. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects. Arzneimittelforschung 39 (1989) 867-876
5. Nakayama T., Hironaga T., Ishima H., Maruyama T., Masubuchi Y., and Kokubun S. The prostacyclin analogue beraprost sodium prevents development of arterial stiffness in elderly patients with cerebral infarction. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004) 491-494
6. Schupp M., Janke J., Clasen R., Unger T., and Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109 (2004) 2054-2057
7. Uchida H., Nakamura Y., Kaihara M., et al. Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension. Hypertens. Res. 27 (2004) 545-550
8. Asmar R., Gosse P., Topouchian J., N'tela G., Dudley A., and Shepherd G.L. Effects of telmisartan on arterial stiffness in type 2 diabetes patients with essential hypertension. J. Renin Angiotensin Aldosterone Syst. 3 (2002) 176-180
9. Kubo M., Kiyohara Y., Kato I., Tanizaki Y., Arima H., Tanaka K., Nakamura H., Okubo K., and Iida M. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 34 (2003) 2349-2354
10. Howe P.R., Rogers P.F., and Lungershausen Y. Blood pressure reduction by fish oil in adult rats with established hypertension-dependence on sodium intake. Prostaglandins Leukot. Essent. Fatty Acids 44 (1991) 113-117
11. Molina V., Arruzazabala M.L., Carbajal D., and Mas R. Synergistic effect of D-003 and aspirin on experimental thrombosis models. Prostaglandins Leukot. Essent. Fatty Acids 68 (2003) 305-310
12. Lantelme P., Mestre C., Lievre M., Gressard A., and Milon H. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension 39 (2002) 1083-1087
13. van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., and van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19 (1988) 604-607
14. Morita A., Nakayama T., Doba N., Hinohara S., and Soma M. Polymorphism of the C reactive protein gene is related to serum CRP level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens. Res. 29 (2006) 323-331
15. Bortolotto L.A., Blacher J., Kondo T., Takazawa K., and Safar M.E. Assessment of vascular aging and atherosclerosis in hypertensive subjects: second derivative of photoplethysmogram versus pulse wave velocity. Am. J. Hypertens. 13 (2000) 165-171
16. Breithaupt-Grogler K., Ling M., Boudoulas H., and Belz G.G. Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation 96 (1997) 2649-2655
17. Hasegawa M., Nagao K., Kinoshita Y., Rodbard D., and Asahina A. Increased pulse wave velocity and shortened pulse wave transmission time in hypertension and aging. Cardiology 88 (1997) 147-151
18. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensives patients. Hypertension 37 (2001) 1236-1241
19. Sasamura H., Kitamura Y., Nakamura M., Ryuzaki M., and Saruta T. Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension. Clin. Exp. Hypertens. 28 (2006) 511-520
20. Moncada S., Gryglewski R.J., Bunting S., and Vane J. An enzyme isolated from arteries that inhibits platelet aggregation. Nature 263 (1976) 663-665
21. Dembinska-Kiec A., Kostka-Trabka E., and Gryglewski R.J. Effect of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans. Thromb. Haemost. 47 (1982) 190
22. Chapleau D.E., and White R.P. Effects of prostacyclin on the canine isolated basilar artery. Prostaglandins 17 (1979) 573-580
23. Uchida Y., and Murao S. Role of prostaglandin 12 and thromboxane A2 in recurring reduction of carotid and cerebral flow in dogs. Stroke 2 (1981) 786-792
24. J.M. Hallenbeck, D.R. Leitgh, A.J. Dutka, U. Greenbaum Jr., PGI2 indomethacin and heparin promote postischemic neuronal recovery in dogs when administered therapeutically, in: K.K. Wu, E.C. Rosse (Ed.), Prostaglandins in Clinical Medicine-Cardiovascular and Thrombotic Disorders, Year Book Medical Publishers, Chicago, London, 1982, pp. 335-341.
25. Vane J.R. Prostaglandins and the cardiovascular system. Br. Heart J. 49 (1983) 405-409